Cite
Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional study
MLA
Lucía Vilanova-Trillo, et al. “Cutaneous Adverse Events and Quality of Life in Outpatients Receiving Anticancer Agents: Results from an Observational, Cross-Sectional Study.” Drugs in Context, vol. 9, Aug. 2020, pp. 1–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....78e29f3337b5131848656cb2d1a10e71&authtype=sso&custid=ns315887.
APA
Lucía Vilanova-Trillo, Hae-Jin Suh Oh, Ángeles Flórez Menéndez, Manuel Pereiro Ferreirós, Francisca Fernández Ribeiro, Víctor Sacristán Santos, & Manuel Constenla Figueiras. (2020). Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional study. Drugs in Context, 9, 1–10.
Chicago
Lucía Vilanova-Trillo, Hae-Jin Suh Oh, Ángeles Flórez Menéndez, Manuel Pereiro Ferreirós, Francisca Fernández Ribeiro, Víctor Sacristán Santos, and Manuel Constenla Figueiras. 2020. “Cutaneous Adverse Events and Quality of Life in Outpatients Receiving Anticancer Agents: Results from an Observational, Cross-Sectional Study.” Drugs in Context 9 (August): 1–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....78e29f3337b5131848656cb2d1a10e71&authtype=sso&custid=ns315887.